JP2019151636A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019151636A5 JP2019151636A5 JP2019071529A JP2019071529A JP2019151636A5 JP 2019151636 A5 JP2019151636 A5 JP 2019151636A5 JP 2019071529 A JP2019071529 A JP 2019071529A JP 2019071529 A JP2019071529 A JP 2019071529A JP 2019151636 A5 JP2019151636 A5 JP 2019151636A5
- Authority
- JP
- Japan
- Prior art keywords
- dengue
- composition
- dengue virus
- serotype
- cyd
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP12305907.3 | 2012-07-24 | ||
| EP12305907 | 2012-07-24 | ||
| EP12305912.3 | 2012-07-25 | ||
| EP12305912 | 2012-07-25 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015523548A Division JP2015524421A (ja) | 2012-07-24 | 2013-07-24 | ワクチン組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019151636A JP2019151636A (ja) | 2019-09-12 |
| JP2019151636A5 true JP2019151636A5 (https=) | 2019-10-24 |
| JP6830118B2 JP6830118B2 (ja) | 2021-02-17 |
Family
ID=48875047
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015523548A Ceased JP2015524421A (ja) | 2012-07-24 | 2013-07-24 | ワクチン組成物 |
| JP2019071529A Active JP6830118B2 (ja) | 2012-07-24 | 2019-04-03 | ワクチン組成物 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015523548A Ceased JP2015524421A (ja) | 2012-07-24 | 2013-07-24 | ワクチン組成物 |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US20150196631A1 (https=) |
| EP (2) | EP2877208B1 (https=) |
| JP (2) | JP2015524421A (https=) |
| KR (2) | KR20150036592A (https=) |
| CN (1) | CN104812407B (https=) |
| AU (1) | AU2013295014B2 (https=) |
| MX (2) | MX381497B (https=) |
| MY (2) | MY197723A (https=) |
| PH (1) | PH12014502840B1 (https=) |
| SG (2) | SG10201912291YA (https=) |
| WO (1) | WO2014016360A1 (https=) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2013295016A1 (en) * | 2012-07-24 | 2015-01-29 | Sanofi Pasteur | Vaccine compositions for prevention against dengue virus infection |
| EP2968516B1 (en) | 2013-03-15 | 2022-01-12 | Takeda Vaccines, Inc. | Compositions and methods for dengue virus chimeric constructs in vaccines |
| TWI852899B (zh) | 2014-09-02 | 2024-08-21 | 法商賽諾菲巴斯德公司 | 疫苗組合物 |
| WO2016130321A1 (en) * | 2015-02-09 | 2016-08-18 | Academia Sinica | An epitope-substituted vaccine for use in improving safety and immunogenicity against dengue viruses |
| EP3316905A1 (en) * | 2015-07-03 | 2018-05-09 | Sanofi Pasteur | Concomitant dengue and yellow fever vaccination |
| EP3147294B1 (en) * | 2015-09-24 | 2020-04-29 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Distinguishing dengue virus infections from other flaviviral infections using a recombinant mutant envelope protein |
| KR102373570B1 (ko) * | 2015-11-27 | 2022-03-10 | 케이엠 바이올로직스 가부시키가이샤 | 뎅기 바이러스 약독주를 뱅크화한 생바이러스, 및 그것들을 항원으로 하는 뎅기 백신 |
| JP2019511533A (ja) * | 2016-04-13 | 2019-04-25 | タケダ ワクチン, インコーポレイテッドTakeda Vaccines, Inc. | 小児及び若年成人のデングウイルスに対するワクチンの組成物及び方法 |
| US11531029B2 (en) | 2017-05-08 | 2022-12-20 | University Of Pittsburgh-Of The Commonwealth System Of Higher Education | Methods and compositions for the detection of flavivirus infections |
| WO2019069130A1 (en) * | 2017-10-05 | 2019-04-11 | Sanofi Pasteur | COMPOSITIONS FOR RECALL VACCINATION AGAINST DENGUE |
| US11491217B2 (en) | 2017-12-06 | 2022-11-08 | Emory University | Chimeric viruses encoding mutant zika virus envelope glycoproteins |
| EP3549603A1 (en) | 2018-04-06 | 2019-10-09 | Sanofi Pasteur | Live-attenuated yellow fever virus strain adapted to grow on vero cells and vaccine composition comprising the same |
| EP3846849A1 (en) | 2018-09-05 | 2021-07-14 | Takeda Vaccines, Inc. | Dengue vaccine unit dose and administration thereof |
| US11426461B2 (en) | 2018-09-05 | 2022-08-30 | Takeda Vaccines, Inc. | Methods for preventing dengue and hepatitis A |
| US11464815B2 (en) | 2018-09-05 | 2022-10-11 | Takeda Vaccines, Inc. | Dengue vaccine unit dose and administration thereof |
| CN112079934B (zh) * | 2019-12-17 | 2021-01-29 | 合源生物科技(天津)有限公司 | 一种靶向cd19的嵌合抗原受体及其用途 |
| CN116334070B (zh) * | 2023-02-15 | 2026-02-06 | 天津大学 | 融合蛋白的应用和细胞融合的方法 |
Family Cites Families (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5422A (en) | 1848-02-01 | Spark-arrester | ||
| US109A (en) | 1836-12-15 | Erawijtg | ||
| CA2017507C (en) | 1989-05-25 | 1996-11-12 | Gary Van Nest | Adjuvant formulation comprising a submicron oil droplet emulsion |
| FR2649012B1 (fr) | 1989-07-03 | 1991-10-25 | Seppic Sa | Emulsions multiphasiques injectables |
| FR2649013B1 (fr) | 1989-07-03 | 1991-10-25 | Seppic Sa | Vaccins et vecteurs de principes actifs fluides contenant une huile metabolisable |
| GB9326253D0 (en) | 1993-12-23 | 1994-02-23 | Smithkline Beecham Biolog | Vaccines |
| US6254873B1 (en) | 1995-04-17 | 2001-07-03 | The United States Of America As Represented By The Secretary Of The Army | Inactivated dengue virus vaccine |
| WO1996040933A1 (en) | 1995-06-07 | 1996-12-19 | The Government Of The United States Of America, Represented By The Secretary Department Of Health And Human Services | Infectious dengue 2 virus pdk-53 as quadravalent vaccine |
| EP0977587B1 (en) | 1997-02-28 | 2005-06-15 | Acambis Inc. | Chimeric flavivirus vaccines |
| GB9711990D0 (en) | 1997-06-11 | 1997-08-06 | Smithkline Beecham Biolog | Vaccine |
| AU1145699A (en) | 1997-09-05 | 1999-03-22 | Smithkline Beecham Biologicals (Sa) | Oil in water emulsions containing saponins |
| GB9718901D0 (en) | 1997-09-05 | 1997-11-12 | Smithkline Beecham Biolog | Vaccine |
| WO2000057909A2 (en) | 1999-03-26 | 2000-10-05 | Walter Reed Army Institute Of Research | Attenuated dengue-2 virus vaccine |
| CA2368790A1 (en) | 1999-03-26 | 2000-10-05 | Walter Reed Army Institute Of Research | Attenuated dengue-3 virus vaccine |
| US6537557B1 (en) | 1999-03-26 | 2003-03-25 | The United States Of America As Represented By The Secretary Of The Army | Attenuated dengue-4 virus vaccine |
| JP2002540169A (ja) | 1999-03-26 | 2002-11-26 | ウォルター リード アーミー インスティテュート オブ リサーチ | 弱毒化デング熱１型ウイルスワクチン |
| ATE526411T1 (de) | 2000-02-16 | 2011-10-15 | Us Gov Health & Human Serv | Avirulente, immunogene flavivirus-chimäre |
| ATE412738T1 (de) | 2000-05-30 | 2008-11-15 | Univ Mahidol | Attenuierte stammen von denguevirus und ihre verwendungen in impfstoffzusammensetzungen |
| AT410634B (de) | 2001-02-21 | 2003-06-25 | Franz X Dr Heinz | Attenuierte lebendimpfstoffe |
| CA2966716C (en) | 2001-05-22 | 2019-11-26 | The Government Of The United States Of America, As Represented By The Cretary, Department Of Health And Human Services | Development of mutations useful for attenuating dengue viruses and chimeric dengue viruses |
| WO2002095007A2 (en) | 2001-05-23 | 2002-11-28 | Dendreon San Diego Llc | Conjugates activated by cell surface proteases and therapeutic uses thereof |
| CN1551782A (zh) | 2001-06-01 | 2004-12-01 | ��������ķ������ | 嵌合黄病毒载体 |
| KR101074175B1 (ko) * | 2002-01-15 | 2011-10-14 | 사노피 파스테르 바이오로직스 씨오 | 플라비바이러스 백신 |
| US20040259224A1 (en) * | 2002-05-31 | 2004-12-23 | Farshad Guirakhoo | Tetravalent Dengue vaccines |
| CA2611954C (en) | 2005-06-17 | 2014-01-28 | Sanofi Pasteur | Dengue serotype 2 attenuated strain |
| CN101238144B (zh) * | 2005-06-17 | 2012-09-05 | 赛诺菲巴斯德有限公司 | 登革血清型1减毒株 |
| AR054822A1 (es) | 2005-07-07 | 2007-07-18 | Sanofi Pasteur | Emulsion inmuno adyuvante |
| JP5227172B2 (ja) | 2005-08-10 | 2013-07-03 | サノフィ パスツール バイオロジクス リミテッド ライアビリティ カンパニー | デングウイルス感染に対するワクチン接種 |
| KR101357685B1 (ko) * | 2005-11-21 | 2014-02-06 | 사노피 파스퇴르 리미티드 / 사노피 파스퇴르 리미떼 | 재조합 바이러스용 안정화 제형 |
| US7968102B2 (en) * | 2006-01-13 | 2011-06-28 | Sanofi Pasteur S.A. | Dengue chimeric viruses |
| FR2896162B1 (fr) | 2006-01-13 | 2008-02-15 | Sanofi Pasteur Sa | Emulsion huile dans eau thermoreversible |
| FR2903605A1 (fr) | 2006-07-12 | 2008-01-18 | Sanofi Pasteur Sa | Methode d'immunisation contre les quatres serotypes de la dengue |
| FR2906724B1 (fr) * | 2006-10-04 | 2009-03-20 | Sanofi Pasteur Sa | Methode d'immunisation contre les 4 serotypes de la dengue. |
| FR2909286B1 (fr) | 2006-12-01 | 2012-06-08 | Sanofi Pasteur | Methode d'immunisation contre les 4 serotypes de la dengue |
| EP2143440A1 (fr) | 2008-07-09 | 2010-01-13 | Sanofi Pasteur | Agent stabilisant et composition vaccinale comprenant un ou plusieurs flavivirus vivants atténués |
| GB201007531D0 (en) | 2010-05-05 | 2010-06-23 | Imp Innovations Ltd | Composition |
-
2013
- 2013-07-24 SG SG10201912291YA patent/SG10201912291YA/en unknown
- 2013-07-24 KR KR20157003821A patent/KR20150036592A/ko not_active Ceased
- 2013-07-24 MY MYPI2018700631A patent/MY197723A/en unknown
- 2013-07-24 AU AU2013295014A patent/AU2013295014B2/en active Active
- 2013-07-24 MX MX2015000442A patent/MX381497B/es unknown
- 2013-07-24 KR KR1020207016038A patent/KR20200067938A/ko not_active Ceased
- 2013-07-24 CN CN201380049627.XA patent/CN104812407B/zh active Active
- 2013-07-24 MY MYPI2014003501A patent/MY168959A/en unknown
- 2013-07-24 US US14/416,496 patent/US20150196631A1/en not_active Abandoned
- 2013-07-24 SG SG11201500412TA patent/SG11201500412TA/en unknown
- 2013-07-24 EP EP13741748.1A patent/EP2877208B1/en active Active
- 2013-07-24 EP EP21173406.6A patent/EP3932422A1/en active Pending
- 2013-07-24 WO PCT/EP2013/065667 patent/WO2014016360A1/en not_active Ceased
- 2013-07-24 JP JP2015523548A patent/JP2015524421A/ja not_active Ceased
-
2014
- 2014-12-19 PH PH12014502840A patent/PH12014502840B1/en unknown
-
2015
- 2015-01-09 MX MX2021004211A patent/MX2021004211A/es unknown
-
2018
- 2018-09-06 US US16/123,319 patent/US20190201517A1/en not_active Abandoned
-
2019
- 2019-04-03 JP JP2019071529A patent/JP6830118B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019151636A5 (https=) | ||
| Christensen et al. | Profound protection against respiratory challenge with a lethal H7N7 influenza A virus by increasing the magnitude of CD8+ T-cell memory | |
| JP2015524421A5 (https=) | ||
| JP2017526689A5 (https=) | ||
| JP2019526580A5 (https=) | ||
| Baehner et al. | Vaccines against norovirus: state of the art trials in children and adults | |
| Chernokhaeva et al. | Protective immunity spectrum induced by immunization with a vaccine from the TBEV strain Sofjin | |
| BRPI0614265A2 (pt) | uso de uma vacina do vìrus da febre amarela e de uma vacina de flavivìrus quimérico e kit contendo referidas vacinas | |
| CA2755257A1 (en) | Replication-defective flavivirus vaccine vectors against respiratory syncytial virus | |
| EP3474891B1 (en) | Vaccine compositions comprising an attenuated mutant zika virus | |
| JP5675789B2 (ja) | 免疫接種のための発現ベクターとしての水疱性口内炎ウイルスの異なる複数の抗原型 | |
| Jiang et al. | Polio endgame: Lessons for the global rotavirus vaccination program | |
| JP2016504315A5 (https=) | ||
| Moreno et al. | Recombinant Rift Valley fever viruses encoding bluetongue virus (BTV) antigens: Immunity and efficacy studies upon a BTV-4 challenge | |
| CN105473603A (zh) | 用于登革病毒疫苗的方法与组合物 | |
| Babaeimarzangou et al. | Vaccine development for zoonotic viral diseases caused by positive‑sense single‑stranded RNA viruses belonging to the Coronaviridae and Togaviridae families | |
| US20230210980A1 (en) | Chimeric adenoviral vectors | |
| US10590174B2 (en) | Genomic sequences encoding for an attenuated mutant Zika virus | |
| Schäfer et al. | Pre-clinical efficacy and safety of experimental vaccines based on non-replicating vaccinia vectors against yellow fever | |
| CN102847147B (zh) | 番鸭细小病毒病和番鸭呼肠孤病毒病二联活疫苗 | |
| JP6259831B2 (ja) | Ｃ型肝炎ウイルスに対するキメラワクチン抗原 | |
| JP2020536107A5 (https=) | ||
| Morrison et al. | Viral vaccines: fighting viruses with vaccines | |
| Xie et al. | Advances in vaccinia virus-based vaccine vectors, with applications in flavivirus vaccine development | |
| Hertel et al. | Prevention of cholestasis in the murine rotavirus-induced biliary atresia model using passive immunization and nonreplicating virus-like particles |